A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
Fadlo R. Khuri(The University of Texas MD Anderson Cancer Center), John Nemunaitis(Texas Oncology), Ian Ganly(University of Glasgow), James C. Arseneau(Texas Oncology), Ian F. Tannock(Princess Margaret Hospital), L. Romel, Martin Gore(Royal Marsden Hospital), J. Ironside(Western General Hospital), R.H. MacDougall(Western General Hospital), Carla Heise, Britta Randlev, Ann M. Gillenwater(The University of Texas MD Anderson Cancer Center), Patricia A. Bruso(The University of Texas MD Anderson Cancer Center), Stanley B. Kaye(University of Glasgow), Waun Ki Hong(The University of Texas MD Anderson Cancer Center), David H. Kirn(The Honourable Society of Lincoln's Inn)
Cited by 1,102
Abstract
Related Papers
No related papers found
Powered by citation graph analysis